Gilead’s Remdesivir Will Be Distributed By State Health Departments
NIH kicks off combo study on the impact of Eli Lilly’s Olumiant on Covid-19 cases — using a dose rejected as too dangerous for RA
Ex-AstraZeneca exec Kristen Buck hops aboard Icon as CMO; Immunocore taps Brian DiDonato as CFO
Two years after a wrenching setback, Protagonist touts a slice of data and sets sights on pivotal trial in a surprising place: the blood
Moderna Pops 15% On FDA Approval For Phase 2 Covid-19 Vaccine Trial
Flagship-backed Evelo Biosciences joins Covid-19 hunt with proposal for microbiome trial
Japan Plans To Approve Gilead's Remdesivir Today- Report
Capricor (CAPR) Shares Could Hit $10, Says Analyst
Analyst Believes Potential COVID-19 Treatment Can Push Ahersys (ATHX) Stock up to $12
AstraZeneca Wins FDA Approval For Diabetes Drug to Treat Heart Failure
AstraZeneca's blockbuster Farxiga secures landmark approval in heart failure patients, regardless of whether they have diabetes
Gilead in Talks to Ramp Up Global Supply of Remdesivir Production
Pfizer, BioNTech Shares Rise on U.S. Coronavirus Vaccine Trial Start
FDA creates umbrella emergency pathway for COVID-19 serology tests
JPMorgan's Bullish Stance on Gilead Sciences (GILD) Stock Comes to an End
UPDATED: FDA cheers on Gilead's remdesivir with a snap emergency OK, giving biopharma a shot at redemption
Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt
Gilead Says Remdesivir Will Be Available To Patients This Week
Roche Gets Emergency FDA Approval For Covid-19 Antibody Test, Starts Shipping
Gilead Down 5% As Q1 Earnings Spark Street Downgrades
Gilead’s Remdesivir Receives Emergency FDA Approval; Here's What This Five-Star Analyst Has To Say
SFU professor’s invention approved by FDA to help wean COVID-19 patients from ventilators
High-profile R&D specialist David Lebwohl jumps to new job as CMO of a pioneering CRISPR player; Troubled AMAG Pharmaceuticals taps Scott Myers as CEO
Troubled AMAG Pharmaceuticals taps Scott Myers as CEO and president; Cheryl Blanchard secures CEO title at Anika Therapeutics